Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$184,550.70
% of Total Estimate Gain
10.68%

Marshall Financial Group, LLC's Halozyme Therapeutics Inc Holding Summary

As of 2025-06-30, Marshall Financial Group, LLC held - shares of Halozyme Therapeutics Inc(HALO), totaling N/A. This investment constitutes 0% of their stock portfolio, and Marshall Financial Group, LLC now holds 0% of the outstanding Halozyme Therapeutics Inc(HALO) stock.

The initial trade took place in 2024Q4. And since then Marshall Financial Group, LLC has made 2 purchases of HALO, at an average price of $51.51, for a total of 33,545.00 shares. In addition, there have been 1 sales at an average price of $57.01 for 33,545.00 shares. Based on historical transaction data and HALO's current price of $57.54, Marshall Financial Group, LLC's estimated gain on his HALO holdings is $184,550.70, reflecting a 10.68% gain to date.

Marshall Financial Group, LLC HALO ($57.54) Holding Chart

Marshall Financial Group, LLC HALO ($57.54) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1